Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 4:25 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 08-Apr-24 | Option Exercise | 69,107 | $3.76 | $259,842.00 | 6% 1.12M to 1.19M | |
| 09-Apr-24 4:25 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Apr-24 | Planned Option Sale | 69,107 | $54.17 | $3,743,610.00 | (6%) 1.19M to 1.12M | |
| 11-Mar-24 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Mar-24 | Option Exercise | 69,107 | $3.67 | $253,623.00 | 6% 1.12M to 1.19M | |
| 11-Mar-24 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Mar-24 | Planned Option Sale | 69,107 | $62.19 | $4,297,550.00 | (6%) 1.19M to 1.12M | |
| 13-Feb-24 4:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 1,148 | $67.77 | $77,796.40 | (< 1%) 1.12M to 1.12M | |
| 31-Jan-24 4:21 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 874 | $64.14 | $56,056.80 | (< 1%) 1.12M to 1.12M | |
| 23-Jan-24 6:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 3,913 | $65.00 | $254,329.00 | (< 1%) 1.12M to 1.12M | |
| 17-Jan-24 4:47 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 6,743 | -- | -- | < 1% 1.12M to 1.12M | |
| 17-Jan-24 4:47 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 1,632 | $66.81 | $109,032.00 | (< 1%) 1.12M to 1.12M | |
| 15-Nov-23 4:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Nov-23 | Option Exercise | 45,000 | $3.76 | $169,200.00 | 4% 1.07M to 1.12M | |
| 09-Nov-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Nov-23 | Option Exercise | 17,494 | $2.67 | $46,709.00 | 2% 1.07M to 1.08M | |
| 09-Nov-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Nov-23 | Planned Option Sale | 12,000 | $47.27 | $567,240.00 | (1%) 1.08M to 1.07M | |
| 10-Oct-23 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 09-Oct-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.06M to 1.08M | |
| 10-Oct-23 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 09-Oct-23 | Planned Option Sale | 12,000 | $40.38 | $484,560.00 | (1%) 1.08M to 1.07M | |
| 11-Sep-23 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Sep-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.05M to 1.07M | |
| 11-Sep-23 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Sep-23 | Option Sale | 12,000 | $42.87 | $514,440.00 | (1%) 1.07M to 1.06M | |
| 09-Aug-23 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.05M to 1.07M | |
| 09-Aug-23 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-23 | Planned Option Sale | 12,000 | $23.66 | $283,920.00 | (1%) 1.07M to 1.05M | |
| 11-Jul-23 5:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Jul-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.04M to 1.06M | |
| 11-Jul-23 5:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Jul-23 | Planned Option Sale | 12,000 | $84.55 | $1,014,600.00 | (1%) 1.06M to 1.05M | |
| 09-Jun-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Jun-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.03M to 1.05M | |
| 09-Jun-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Jun-23 | Planned Option Sale | 12,000 | $91.35 | $1,096,200.00 | (1%) 1.05M to 1.04M | |
| 09-May-23 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-May-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.03M to 1.05M | |
| 09-May-23 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-May-23 | Planned Option Sale | 12,000 | $92.39 | $1,108,680.00 | (1%) 1.05M to 1.03M | |
| 11-Apr-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Apr-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.02M to 1.04M | |
| 11-Apr-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Apr-23 | Planned Option Sale | 12,000 | $78.21 | $938,520.00 | (1%) 1.04M to 1.03M | |
| 10-Mar-23 5:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Mar-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.01M to 1.03M | |
| 10-Mar-23 5:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Mar-23 | Planned Option Sale | 12,000 | $63.79 | $765,480.00 | (1%) 1.03M to 1.02M | |
| 22-Feb-23 6:44 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 9,886 | -- | -- | < 1% 1.01M to 1.02M | |
| 22-Feb-23 6:44 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 1,195 | $58.50 | $69,907.50 | (< 1%) 1.02M to 1.01M | |
| 14-Feb-23 4:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 1,134 | $51.21 | $58,072.10 | (< 1%) 1.01M to 1.01M | |
| 10-Feb-23 5:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Feb-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 1.0M to 1.02M | |
| 10-Feb-23 5:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Feb-23 | Planned Option Sale | 12,000 | $54.45 | $653,400.00 | (1%) 1.02M to 1.01M | |
| 30-Jan-23 4:47 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 832 | $52.77 | $43,904.60 | (< 1%) 1.0M to 1.0M | |
| 24-Jan-23 5:14 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 2,326 | $52.05 | $121,068.00 | (< 1%) 1.0M to 1.0M | |
| 17-Jan-23 7:33 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 19,634 | -- | -- | 2% 983.78K to 1.0M | |
| 10-Jan-23 8:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 09-Jan-23 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 977.28K to 995.78K | |
| 10-Jan-23 8:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 09-Jan-23 | Planned Option Sale | 12,000 | $46.08 | $552,960.00 | (1%) 995.78K to 983.78K | |
| 30-Dec-22 5:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Dec-22 | Option Exercise | 7,000 | $3.67 | $25,690.00 | < 1% 970.28K to 977.28K | |
| 12-Dec-22 4:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Dec-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 963.78K to 982.28K | |
| 12-Dec-22 4:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Dec-22 | Planned Option Sale | 12,000 | $47.50 | $570,000.00 | (1%) 982.28K to 970.28K | |
| 10-Nov-22 8:30 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Nov-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 957.28K to 975.78K | |
| 10-Nov-22 8:30 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Nov-22 | Planned Option Sale | 12,000 | $46.47 | $557,640.00 | (1%) 975.78K to 963.78K | |
| 11-Oct-22 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Oct-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 950.78K to 969.28K | |
| 11-Oct-22 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Oct-22 | Planned Option Sale | 12,000 | $57.50 | $690,000.00 | (1%) 969.28K to 957.28K | |
| 12-Sep-22 4:52 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Sep-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 944.28K to 962.78K | |
| 12-Sep-22 4:52 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Sep-22 | Planned Option Sale | 12,000 | $63.98 | $767,760.00 | (1%) 962.78K to 950.78K | |
| 09-Aug-22 5:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 937.78K to 956.28K | |
| 09-Aug-22 5:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Aug-22 | Planned Option Sale | 12,000 | $62.50 | $750,000.00 | (1%) 956.28K to 944.28K | |
| 12-Jul-22 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Jul-22 | Option Exercise | 18,500 | $2.67 | $49,395.00 | 2% 931.28K to 949.78K |